Cargando…

Intravenous enoxaparin as alternative ECMO anticoagulation over a period of 94 days: a case report

BACKGROUND: Unfractionated heparin is used worldwide as a standard anticoagulation therapy for extracorporeal membrane oxygenation (ECMO) machines. However, its use brings about significant bleeding and thrombotic complications for critically ill patients. This case report shows that low molecular w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Durila, Miroslav, Berousek, Jan, Vlasakova, Vlasta, Vymazal, Tomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088682/ https://www.ncbi.nlm.nih.gov/pubmed/37041623 http://dx.doi.org/10.1186/s13019-023-02226-0

Ejemplares similares

Tracheostomy in intensive care unit patients can be performed without bleeding complications in case of normal thromboelastometry results (EXTEM CT) despite increased PT-INR: a prospective pilot study
por: Durila, Miroslav, et al.
Publicado: (2015)

Effect of targeted coagulopathy management and 5% albumin as volume replacement therapy during lung transplantation on allograft function: a secondary analysis of a randomized clinical trial
por: Vajter, Jaromir, et al.
Publicado: (2023)

Rotational thromboelastometry assessment of ballanced crystalloid, hydroxyethyl starch and gelatin effects on coagulation: a randomized trial
por: Sevcikova, Silvie, et al.
Publicado: (2019)

Utility of rotational thromboelastometry in total hip replacement revision surgery (case-control study)
por: Jonas, J., et al.
Publicado: (2020)

Evaluation of Thromboelastometry in Sepsis in Correlation With Bleeding During Invasive Procedures
por: Lukas, Pavel, et al.
Publicado: (2017)

Argatroban for an alternative anticoagulant in HIT during ECMO
por: Rougé, Alain, et al.
Publicado: (2017)

Anticoagulation on extracorporeal membrane oxygenation (ECMO)
por: Khilnani, Praveen
Publicado: (2017)

Is it time to switch to bivalirudin for ECMO anticoagulation?
por: Navaei, Amir, et al.
Publicado: (2023)

Intermittent versus continuous enoxaparine for anticoagulation during continuous venovenous hemofiltration
por: Koroljov, A, et al.
Publicado: (2008)

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
por: Inchiosa, Mario A., et al.
Publicado: (2012)

Retrospective Evaluation of Intravenous Enoxaparin Administration in Feline Arterial Thromboembolism
por: Mitropoulou, Athanasia, et al.
Publicado: (2022)

ECMO in pregnancy and the peripartum period
por: Brodie, Daniel
Publicado: (2017)

Uninterrupted Continuation of VV-ECMO Without Anticoagulation for 44 Days in COVID-19 ARDS: A Precarious Quandary
por: Patel, Sankalp P., et al.
Publicado: (2022)

No Time Dependence of Ciprofloxacin Pharmacokinetics in Critically Ill Adults: Comparison of Individual and Population Analyses
por: Šíma, Martin, et al.
Publicado: (2021)

Prophylactic anticoagulation with low dose enoxaparin: is the subcutaneous route appropriate in the critically ill?
por: Priglinger, U, et al.
Publicado: (2002)

Comparative Studies on the Anticoagulant Profile of Branded Enoxaparin and a New Biosimilar Version
por: Qneibi, Dalia, et al.
Publicado: (2020)

ECMO for a polytrauma patient without systemic anticoagulation
por: Abdelaty, Mohamed, et al.
Publicado: (2017)

Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO
por: Chlebowski, Meghan M., et al.
Publicado: (2020)

Anticoagulation Management in High Bleeding-Risk ECMO in Adults
por: De Paulis, Stefano, et al.
Publicado: (2022)

ECMO-treatment in patients with acute lung failure, cardiogenic, and septic shock: mortality and ECMO-learning curve over a 6-year period
por: Banjas, Norbert, et al.
Publicado: (2018)

Subcutaneous Enoxaparin for Systemic Anticoagulation of COVID-19 Patients During Extracorporeal Life Support
por: Wiegele, Marion, et al.
Publicado: (2022)

Enoxaparin as an Anticoagulant in a Multipara with a Mechanical Mitral Valve: A Case Report
por: Lee, Yo Seb, et al.
Publicado: (2023)

Anticoagulation in Neonatal ECMO: An Enigma Despite a Lot of Effort!
por: Cashen, Katherine, et al.
Publicado: (2019)

The Role of Excessive Anticoagulation and Missing Hyperinflammation in ECMO-Associated Bleeding
por: Rajsic, Sasa, et al.
Publicado: (2022)

Update on Anticoagulation Strategies in Patients with ECMO—A Narrative Review
por: Šoltés, Ján, et al.
Publicado: (2023)

300 plus days on ECMO – lessons learned
por: Raza, Tasleem
Publicado: (2017)

Correction to: ECMO-treatment in patients with acute lung failure, cardiogenic, and septic shock: mortality and ECMO-learning curve over a 6-year period
por: Banjas, Norbert, et al.
Publicado: (2019)

Limited diagnostic possibilities for bloodstream infections with broad‐range methods: A promising PCR/electrospray ionization‐mass spectrometry platform is no longer available
por: Tkadlec, Jan, et al.
Publicado: (2020)

Factors Affecting the Metabolic Conversion of Ciprofloxacin and Exposure to Its Main Active Metabolites in Critically Ill Patients: Population Pharmacokinetic Analysis of Desethylene Ciprofloxacin
por: Šíma, Martin, et al.
Publicado: (2022)

Anticoagulant properties of enoxaparin 400 IU/mL–40 % ethanol catheter lock solution
por: Calvet, Laure, et al.
Publicado: (2015)

Fondaparinux versus Enoxaparin - Which is the Best Anticoagulant for Acute Coronary Syndrome? - Brazilian Registry Data
por: Soeiro, Alexandre de Matos, et al.
Publicado: (2016)

Anticoagulation strategies in COVID-19 infected patients receiving ECMO support
por: Diaz, Dayne, et al.
Publicado: (2023)

Does evolution of pre-ECMO conventional therapies affect the use of ECMO over the past decade in the regional ECMO centre in UK?
por: Najafi, N, et al.
Publicado: (2002)

ECMO for Cardiac Rescue after Accidental Intravenous Mepivacaine Application
por: Froehle, Michael, et al.
Publicado: (2012)

Comparison of anticoagulation strategies for veno-venous ECMO support in acute respiratory failure
por: Seeliger, Benjamin, et al.
Publicado: (2021)

Efficacy of Bivalirudin for Therapeutic Anticoagulation in COVID-19 Patients Requiring ECMO Support
por: Trigonis, Russell, et al.
Publicado: (2022)

Intravenous immunoglobulin fails to improve ARDS in patients undergoing ECMO therapy
por: Prohaska, Stefanie, et al.
Publicado: (2018)

Venous Thrombosis in Multiple Sclerosis Patients after High-Dose Intravenous Methylprednisolone: The Preventive Effect of Enoxaparin
por: Kalanie, Hossein, et al.
Publicado: (2011)

Fatigue of red blood cells under periodic squeezes in ECMO
por: Pan, Yunfan, et al.
Publicado: (2022)

Awake ECMO without anticoagulation for nearly completely obstructive squamous cell carcinoma of the trachea
por: Klug, Theodore D., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_agfjtsp84d3c4327dgvk4ct7v5